Qube Research & Technologies (QRT)
HLVX

Qube Research & Technologies (QRT)’s HilleVax HLVX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-49,963
Closed -$99.4K – 3747
2025
Q2 		$99.4K Buy
+49,963
New +$91.4K ﹤0.01% 3037
2024
Q2 		– Sell
-5,056
Closed -$84.1K – 4193
2024
Q1 		$84.1K Buy
+5,056
New +$80.9K ﹤0.01% 3365
2023
Q4 		– Sell
-393
Closed -$5.29K – 4502
2023
Q3 		$5.29K Buy
+393
New +$5.53K ﹤0.01% 3442

Qube Research & Technologies (QRT)'s HLVX Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 49,963 shares — an estimated $99.4K sold.

Qube Research & Technologies (QRT) first reported a position in HLVX in Q3 2023 and held it in 3 quarters. The position peaked at $99.4K in Q2 2025. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

  • Qube Research & Technologies (QRT) reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 49,963 HilleVax shares in Q3 2025, an estimated $99.4K.
  • Qube Research & Technologies (QRT) first reported a position in HilleVax in Q3 2023 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s HilleVax position peaked at $99.4K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.